Metraipolis › archive › dc_953ee680f3ec

Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal — Europe PMC PMID:40829176

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40829176
DOI
10.1172/jci194924
License (as archived)
solo-consultazione
Archived
2026-11-10T14:20:54.240Z
SHA-256 of the archived text
173e453c53248c5a7d0845b20cd8af757e2fff7a3beeb5a18a58a762325b272f
Stable URL of this page
https://metraipolis.com/documento/dc_953ee680f3ec

How to cite

Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal — Europe PMC PMID:40829176 — Europe PMC (en), https://europepmc.org/article/MED/40829176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_953ee680f3ec (Metraipolis archive dc_953ee680f3ec, sha256 173e453c53248c5a7d0845b20cd8af757e2fff7a3beeb5a18a58a762325b272f)
BibTeX
@misc{dc953ee680f3ec,
  title = {Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal — Europe PMC PMID:40829176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40829176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_953ee680f3ec; sha256 173e453c53248c5a7d0845b20cd8af757e2fff7a3beeb5a18a58a762325b272f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40829176. Agents can read the archived copy with the MCP tool read_document.